Nasdaq dbtx.
DBX NASDAQ. DBX NASDAQ. DBX NASDAQ. DBX NASDAQ. Market closed Market closed. No trades. See on Supercharts. Overview . News Ideas Financials Technicals Forecast . DBX chart. Today 0.93% 5 days −1.40% 1 month −4.98% 6 months 20.14% Year to date 15.52% 1 year 21.65% 5 years 4.77% All time −9.90%. Key stats.
USA, PLSE, NASDAQ. 080134288, Synergy Chc Corp. USA, SNYR, OTHER OTC Market. 080143728, Decibel Therapeutics, Inc. USA, DBTX, NASDAQ. 080144027, Ulta Beauty, ...BOSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, March 21, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Sep 12, 2023 · Decibel Therapeutics, Inc. (Nasdaq: DBTX), relating to its proposed acquisition by Regeneron Pharmaceuticals, Inc. Under the terms of the tender offer, DBTX shareholders will receive $4.00 in cash ...
Aug 10, 2023 · I am 57 and have $1.1 million in my 401(k) and $50,000 in a high-yield savings account. I earn $300,000 per year and put $30,000 in my 401(k) each year plus a match on the first 6%. BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, May 15, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today reported financial results for the first quarter ended March 31, 2023 and provided a corporate update.
BOSTON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...
Decibel Therapeutics Inc (NASDAQ: DBTX) announced the presentation of preclinical data on DB-OTO, its lead gene therapy product candidate. DB-OTO is a dual-vector adeno-associated candidate ...See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial. …BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Decibel Therapeutics, Inc. (Nasdaq - DBTX) Under the terms of the Merger Agreement, Decibel will be acquired by Regeneron Pharmaceuticals, Inc. (Nasdaq - REGN). Decibel shareholders will receive ...
August 09 2023 - 08:14AMDow Jones News. By Dean Seal. Regeneron Pharmaceuticals agreed to acquire Decibel Therapeutics for $4 a share, marking a 43% …
Motley Fool Issues Rare Triple-Buy Alert. This Stock Could Be Like Buying Amazon for $3.19. Find real-time Symbol not found stock quotes, company profile, news and forecasts from CNN Business.
ABOUT THIS EVENT Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and ...About Nasdaq Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software, and services enables clients ...Decibel Therapeutics, Inc. (Nasdaq: DBTX), relating to its proposed acquisition by Regeneron Pharmaceuticals, Inc. Under the terms of the tender offer, DBTX shareholders will receive $4.00 in cash ...BOSTON, May 10, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...DBTX Latest Real Time Trades. Select time range to see more trades: Last 100 Trades. NLS Time (ET) NLS Price. NLS Share Volume. 16:00:04. $ 4.33. 42.The average one-year price target for Decibel Therapeutics (NASDAQ:DBTX) has been revised to 14.69 / share. This is an increase of 9.37% from the prior estimate of 13.43 dated June 1, 2023. Jan 24, 2023 · Decibel intends to initiate the Phase 1/2 clinical trial of DB-OTO in the first half of 2023. BOSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage ...
Decibel Therapeutics, Inc. (DBTX) NasdaqGS - NasdaqGS Real-time price. Currency in USD. Add to watchlist. 3.2200 +0.2000 (+6.62%) At close: 03:59PM EDT. 1d. 5d. 1m.BOSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com. Media Contact Emily Pan [email protected] +1 (646 ...Every investor in Decibel Therapeutics, Inc. (NASDAQ:DBTX) should be aware of the most powerful shareholder groups. Large companies usually have institutions as shareholders, and we usually see ...Based on analysts offering 12 month price targets for DBTX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .
DECIBEL THERAPEUTICS, INC. Add to a list PDF Report Decibel Therapeutics, Inc. Stock price Equities DBTX US24343R1068 Biotechnology & Medical Research Summary Charts News Calendar Company Funds and ETFs -40% on all our subscriptions* Enjoy this offer * See conditions on website Chart Decibel Therapeutics, Inc. Duration Period Style Dynamic Chart
Aug 9, 2023 · The deal also has an additional contingent payment of $3.50 per share for DBTX stock if certain milestones are met. At the $4 price for DBTX stock, this offer represents a 43.3% premium over its ... BOSTON, March 21, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Decibel Therapeutics, Inc. Common Stock (DBTX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.USA, PLSE, NASDAQ. 080134288, Synergy Chc Corp. USA, SNYR, OTHER OTC Market. 080143728, Decibel Therapeutics, Inc. USA, DBTX, NASDAQ. 080144027, Ulta Beauty, ...BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, June 28, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...According to NASDAQ, as of May 2014, the highest NASDAQ closing ever was achieved on March 9, 2000, when the market closed at a record 5046.86. USA Today reports that the highest closing achieved by NASDAQ since was a 4007.09 closing on Nov...The Decibel Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.TARRYTOWN, N.Y. and BOSTON, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Decibel Therapeutics, Inc. (NASDAQ: DBTX), a clinical-stage biotechnology company ...
Find the latest Institutional Holdings data for Decibel Therapeutics, Inc. Common Stock (DBTX) at Nasdaq.com.
(DBTX) reported a total revenue of $12.5 million in the first quarter of 2022 ... NASDAQ · NYSE · Blog. Need Help? [email protected]. Create your mobile categories ...
18-Sept-2023 ... Decibel Therapeutics, Inc. (Nasdaq: DBTX), relating to its proposed acquisition by Regeneron Pharmaceuticals, Inc. Under the terms of the tender ...The put contract at the $72.00 strike price has a current bid of $2.21. If an investor was to sell-to-open that put contract, they are committing to purchase the stock …Find the latest dividend history for Decibel Therapeutics, Inc. Common Stock (DBTX) at Nasdaq.com. BOSTON, March 18, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today ...BOSTON, June 02, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, June 28, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today reported positive top-line results from an interim analysis of its ongoing Phase 1b clinical trial of DB-020, a ...25-Sept-2023 ... Regeneron Pharmaceuticals, Inc.(NASDAQ:REGN): Growing adoption of AI technologies by biopharmaceutical companies and growing foothold of ...
Decibel Therapeutics, Inc. (Nasdaq: DBTX), relating to its proposed acquisition by Regeneron Pharmaceuticals, Inc. Under the terms of the tender offer, DBTX shareholders will receive $4.00 in cash ...BOSTON, May 17, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Dropbox, Inc. (NASDAQ:DBX) expanded its global footprint in January 2023 when it announced that it has signed an agreement with TjDeeD – a Middle Eastern company – to allow consumers in the ...Decibel Therapeutics Inc. (Nasdaq: DBTX) has extended its research collaboration with Regeneron Pharmaceuticals Inc. (Nasdaq: RGEN) through mid-November 2023. Regeneron will pay Decibel an ...Instagram:https://instagram. how to sell stock on etradecathoe woodsurge tradershow do you invest in startup companies Nov 2, 2022 · Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today ... Dec 3, 2023 · Decibel Therapeutics (NASDAQ:DBTX) has a recorded net income of -$63.01 million. DBTX has generated -$2.53 earnings per share over the last four quarters. What is Decibel Therapeutics's EPS forecast for next year? roth ira 2024 contribution limitbest real estate crowdfunding sites DECIBEL THERAPEUTICS, INC. Add to a list PDF Report Decibel Therapeutics, Inc. Stock price Equities DBTX US24343R1068 Biotechnology & Medical Research Summary Charts News Calendar Company Funds and ETFs -40% on all our subscriptions* Enjoy this offer * See conditions on website Chart Decibel Therapeutics, Inc. Duration Period Style Dynamic Chart Nov 16, 2023 · Decibel Therapeutics (NASDAQ:DBTX) Historical Stock Chart From Oct 2023 to Nov 2023 Decibel Therapeutics (NASDAQ:DBTX) Historical Stock Chart From Nov 2022 to Nov 2023 Latest DBTX Messages cvs stock dividend BOSTON, March 21, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...